Evidence map›Paper›PMID 26535575›Full record

ArticlePloS one2015

Impact of Statins on Gene Expression in Human Lung Tissues.

Jérôme Lane, Stephan F van Eeden, Ma'en Obeidat, Don D Sin, Scott J Tebbutt, Wim Timens, Dirkje S Postma, Michel Laviolette, Peter D Paré, Yohan Bossé

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Innovations in asthma therapy: is there a role for inhaled statins?Expert review of respiratory medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Jérôme LaneInstitut universitaire de cardiologie et de pneumologie de Québec, Quebec City, Canada.
Stephan F van EedenUniversity of British Columbia, Department of Medicine & Center for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Ma'en ObeidatUniversity of British Columbia, Department of Medicine & Center for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Don D SinUniversity of British Columbia, Department of Medicine & Center for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Scott J TebbuttUniversity of British Columbia, Department of Medicine & Center for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Wim TimensUniversity of Groningen, University Medical Center Groningen, GRIAC research institute, Groningen, The Netherlands.
Dirkje S PostmaUniversity of Groningen, University Medical Center Groningen, GRIAC research institute, Groningen, The Netherlands.
Michel LavioletteInstitut universitaire de cardiologie et de pneumologie de Québec, Quebec City, Canada.
Peter D ParéUniversity of British Columbia, Department of Medicine & Center for Heart Lung Innovation, St. Paul's Hospital, Vancouver, Canada.
Yohan BosséInstitut universitaire de cardiologie et de pneumologie de Québec, Quebec City, Canada.
Institut universitaire de cardiologie et de pneumologie de Québec · CAUniversity of British Columbia · CAUniversity Medical Center Groningen · NLPrevention of Organ Failure · CASt. Paul's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statins are 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors that alter the synthesis of cholesterol. Some studies have shown a significant association of statins with improved respiratory health outcomes of patients with asthma, chronic obstructive pulmonary disease and lung cancer. Here we hypothesize that statins impact gene expression in human lungs and may reveal the pleiotropic effects of statins that are taking place directly in lung tissues. Human lung tissues were obtained from patients who underwent lung resection or transplantation. Gene expression was measured on a custom Affymetrix array in a discovery cohort (n = 408) and two replication sets (n = 341 and 282). Gene expression was evaluated by linear regression between statin users and non-users, adjusting for age, gender, smoking status, and other covariables. The results of each cohort were combined in a meta-analysis and biological pathways were studied using Gene Set Enrichment Analysis. The discovery set included 141 statin users. The lung mRNA expression levels of eighteen and three genes were up-regulated and down-regulated in statin users (FDR < 0.05), respectively. Twelve of the up-regulated genes were replicated in the first replication set, but none in the second (p-value < 0.05). Combining the discovery and replication sets into a meta-analysis improved the significance of the 12 up-regulated genes, which includes genes encoding enzymes and membrane proteins involved in cholesterol biosynthesis. Canonical biological pathways altered by statins in the lung include cholesterol, steroid, and terpenoid backbone biosynthesis. No genes encoding inflammatory, proteases, pro-fibrotic or growth factors were altered by statins, suggesting that the direct effect of statin in the lung do not go beyond its antilipidemic action. Although more studies are needed with specific lung cell types and different classes and doses of statins, the improved health outcomes and survival observed in statin users with chronic lung diseases do not seem to be mediated through direct regulation of gene expression in the lung.

Indexed as

AdenocarcinomaAgedBiomarkersCarcinoma, Squamous CellFemaleGene Expression ProfilingGene Expression RegulationHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLung NeoplasmsMaleMiddle AgedOligonucleotide Array Sequence AnalysisPulmonary Disease, Chronic ObstructiveReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionBiomarkersHydroxymethylglutaryl-CoA Reductase InhibitorsRNA, Messenger

Identifiers

PMID26535575
PMCPMC4633125
OpenAlexW2271936122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.